Company Profile

ANUH PHARMA LTD.

NSE : NABSE : 506260ISIN CODE : INE489G01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE150.254.9 (+3.37 % )
PREV CLOSE (Rs.) 145.35
OPEN PRICE (Rs.) 145.40
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 314896
TODAY'S LOW / HIGH (Rs.)145.40 153.45
52 WK LOW / HIGH (Rs.) 90 218.7
NSE
This Company is not listed in NSE

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 1.00
TTM EPS (Rs.) 5.67
P/E Ratio 26.48
Book Value (Rs.) 38.04
Face Value (Rs.) 5
MCap (Rs. in Mn) 7529.33
Price/Earning (TTM) 17.30
Price/Sales (TTM) 1.74
Price/Book (MRQ) 3.95
PAT Margin (%) 4.50
ROCE (%) 10.87
Incorporation Year : 1960

Management Info :

Jasvantlal G Shah - Chairman - Managing Director

Registered Office :

Address : 3 - A, Shivsasgar Estate, North Wing,Dr. Annie Basant Road,Worli,
Mumbai,
Maharashtra-400018

Phone : +91-22-66227575

Email : anuh@sk1932.com

Website : www.anuhpharma.com

Registrar's Details : Bigshare Services Pvt Ltd
Bharat Tin Works Building,1st floor, Opp. Vasant Oasis,Andheri (E),Mumbai
Listing : BSE
NEWS More
26Jul07-26-2021$ Board Meeting Intimation for Prior Intimation Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Board Meeting Intimation fo
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2021 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 6th August, 2021, inter alia: 1)To consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June, 2021; and 2)To consider any other matter with the permission of the Chairman. Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and in compliance with the Company's Code of Conduct for prevention of Insider Trading, the Trading window for dealing in the securities of the Company has been closed for the Designated Persons and their immediate relatives, from Wednesday, 30th June, 2021 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ended June 30, 2021 i.e. upto Sunday, 8th August, 2021 (both days inclusive).
ANUH PHARMA LTD.has informed BSE that the meeting of the Board..
15Jul07-15-2021$Anuh Pharma informs about issuance of duplicate share certificate Anuh Pharma informs about is

Pursuant to Regulation 39(3) of the SEBI (LODR) Regulations, 2015, Anuh Pharma has informed that the Company has issued duplicate share certificates, on receipt of proper documentation from the shareholder: Arvind Amratlal Patel (Folio No: 0000085), as confirmed by Bigshare Services Registrar and Share Transfer Agent of the Company, as per further details are attached.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 39(3) of the SEBI (LODR) Regulations, 20..
08Jul07-08-2021$Anuh Pharma informs about newspaper advertisement Anuh Pharma informs about ne

Anuh Pharma has informed that it has enclosed the copy of newspaper advertisement with respect to the 61st Annual General Meeting of the Company through Video Conferencing (VC) / Other Audio-Visual Means (OAVM), published in the Financial Express and Mumbai Lakshadeep on Thursday, July 08, 2021 in compliance with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Anuh Pharma has informed that it has enclosed the copy of newsp..
25May05-25-2021$Anuh Pharma informs about investor presentation Anuh Pharma informs about in

Anuh Pharma has informed that it submitted the Company's Investor Presentation for the month of May, 2021.

The above information is a part of company’s filings submitted to BSE.


Anuh Pharma has informed that itsubmitted the Company's Investo..
24May05-24-2021$Anuh Pharma informs about earnings call invite Anuh Pharma informs about ea

Anuh Pharma has informed that it attached the link for Earnings Call Invite to be held on Tuesday, 25th May, 2021 at 04.30 PM to discuss the Financial Performance for Quarter & year ended 31st March, 2021.

The above information is a part of company’s filings submitted to BSE.

Anuh Pharma has informed that it attached the link for Earnings..
Financials More
Rs. in Millions
QTR Mar 21 ANNUAL 21
Net Profit8.97000000000001284.37
Gross Profit 16.61 385.52
Operating Profit 56.24551.22
Net Sales 971.474319.6
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
NGL Fine-Chem (BSE)
 3609.00 (5.00%)
M.Cap ( in Cr)
2229.65
Divi's Lab (BSE)
 5007.95 (1.62%)
M.Cap ( in Cr)
132945.34
Glaxosmithkline Phar (BSE)
 1682.75 (4.84%)
M.Cap ( in Cr)
28506.80
SMS Lifesciences (BSE)
 776.60 (7.57%)
M.Cap ( in Cr)
234.79
Procter&Gamble Healt (BSE)
 5492.75 (0.94%)
M.Cap ( in Cr)
9117.63
Shareholding Pattern More
PROMOTERS 70.43 %
NON-INSTITUTION 29.57 %
FI/BANKS/INSURANCE 0 %
MUTUAL FUNDS/UTI 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
Scheme NameHold(%)
Nippon India Pharma Fun...2.44
F & O Quotes